Objectives

After participating in this educational activity, attendees should be able to:
1. Understand the mode of action of mRNA vaccines
2. Describe the key findings from COVID-19 vaccine clinical trials
3. Understand what is known about use of the vaccine among those with special conditions including pregnancy, lactation, and immune compromise
4. Describe plans for phased vaccine distribution

Faculty

Sarah Haessler, MD
Vice-Chair of Clinical Affairs
Hospital Epidemiologist, Baystate Medical Center

Megan Gallagher, MD
Department of Infectious Disease
UMMS - Baystate

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.

                                                                           

Session date: 
Wednesday, January 6, 2021 - 8:00am to 9:00am
Location: 
Webinar Live
MA
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.